Home › NDC Lookup › RxCUI directory › RxCUI 2708994

Buspirone hydrochloride 7.5 MG Oral Capsule — RxCUI 2708994

Name: Buspirone hydrochloride 7.5 MG Oral Capsule (RxCUI 2708994)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 2708994 Semantic clinical drug · SCD ● Current RxNorm concept 6 FDA products 10 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2708994

Official nameBuspirone hydrochloride 7.5 MG Oral Capsule

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asbuspirone HCl 7.5 MG Oral Capsule; buspirone HCl 7.5 MG (equivalent to buspirone 6.8 MG) Oral Capsule

FDA products mapped6

Package NDCs mapped10

Reported Medicaid activity (SDUD)1,326 prescriptions · 4 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Buspirone: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Unlike some anti-anxiety medicines that work quickly, buspirone tends to build up its effect gradually. Most people don't feel the full benefit for a few weeks. That can feel frust...
How long does it take for buspirone to start working?
Either can work, but the key is to be consistent. Food increases how much buspirone your body absorbs, so if you switch back and forth — sometimes eating before it, sometimes not —...
Should I take buspirone with food or on an empty stomach?

📖 Read our full Buspirone guide →

🕸️ Concept Web — How Buspirone hydrochloride 7.5 MG Oral Capsule Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Buspirone hydrochloride 7.5 MG Oral Capsule RxCUI 2708994 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 2

The active substance itself — no strength, form, or brand attached yet.
- Buspirone 1827 IN
- Buspirone hydrochloride 203116 PIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Bucapsol 2714174 BN
Dose forms 13

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Buspirone Oral Capsule 2708989 SCDF
- Buspirone hydrochloride Oral Capsule 2708990 SCDFP
- Buspirone Oral Product 1151372 SCDG
- Buspirone Pill 1151373 SCDG
- Buspirone hydrochloride Oral Product 2660696 SCDGP
- Buspirone hydrochloride Pill 2662536 SCDGP
- Buspirone Oral Capsule [Bucapsol] 2714178 SBDF
- Buspirone hydrochloride Oral Capsule [Bucapsol] 2714179 SBDFP
- +5 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Buspirone hydrochloride 7.5 MG 866110 SCDC
- Buspirone hydrochloride 7.5 MG Oral Capsule [Bucapsol] 2714180 SBD
- Buspirone hydrochloride 7.5 MG [Bucapsol] 2714175 SBDC

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Buspirone hydrochloride 7.5 MG SCDC · 866110
Buspirone Oral Capsule SCDF · 2708989
Buspirone hydrochloride Oral Capsule SCDFP · 2708990
Buspirone Oral Product SCDG · 1151372
Buspirone Pill SCDG · 1151373
Buspirone hydrochloride Oral Product SCDGP · 2660696
Buspirone hydrochloride Pill SCDGP · 2662536

Brand-Name Concepts

Buspirone hydrochloride 7.5 MG Oral Capsule [Bucapsol] SBD · 2714180
Buspirone hydrochloride 7.5 MG [Bucapsol] SBDC · 2714175
Buspirone Oral Capsule [Bucapsol] SBDF · 2714178
Buspirone hydrochloride Oral Capsule [Bucapsol] SBDFP · 2714179
Bucapsol Oral Product SBDG · 2714176
Bucapsol Pill SBDG · 2714177
Bucapsol BN · 2714174

📦 FDA Products & Package NDCs

6 products · 10 package NDCs

10 package NDCs map to RxCUI 2708994 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
42806-0831-01	100 CAPSULE in 1 BOTTLE (42806-831-01)	Buspirone Hydrochloride	EPIC PHARMA, LLC	2025-03-13
42806-0832-01	100 CAPSULE in 1 BOTTLE (42806-832-01)	Buspirone Hydrochloride	EPIC PHARMA, LLC	2025-03-13
42806-0833-18	180 CAPSULE in 1 BOTTLE (42806-833-18)	Buspirone Hydrochloride	EPIC PHARMA, LLC	2025-03-13
42806-0833-60	60 CAPSULE in 1 BOTTLE (42806-833-60)	Buspirone Hydrochloride	EPIC PHARMA, LLC	2025-03-13
81279-0122-30	30 CAPSULE in 1 BOTTLE (81279-122-30)	Bucapsol	PANGEA PHARMACEUTICALS, LLC	2026-04-10
81279-0122-60	60 CAPSULE in 1 BOTTLE (81279-122-60)	Bucapsol	PANGEA PHARMACEUTICALS, LLC	2026-04-10
81279-0123-30	30 CAPSULE in 1 BOTTLE (81279-123-30)	Bucapsol	PANGEA PHARMACEUTICALS, LLC	2026-04-10
81279-0123-60	60 CAPSULE in 1 BOTTLE (81279-123-60)	Bucapsol	PANGEA PHARMACEUTICALS, LLC	2025-12-29
81279-0124-30	30 CAPSULE in 1 BOTTLE (81279-124-30)	Bucapsol	PANGEA PHARMACEUTICALS, LLC	2026-04-10
81279-0124-60	60 CAPSULE in 1 BOTTLE (81279-124-60)	Bucapsol	PANGEA PHARMACEUTICALS, LLC	2025-07-14

Observed labelers: PANGEA PHARMACEUTICALS, LLC (6) · EPIC PHARMA, LLC (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.